BioLineRx Ltd.
BLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,221 | -$60,614 | -$24,951 | -$27,054 |
| Dep. & Amort. | $4,065 | $1,384 | $654 | $703 |
| Deferred Tax | $0 | $0 | $0 | $1,784 |
| Stock-Based Comp. | $1,135 | $2,321 | $2,245 | $1,495 |
| Change in WC | -$21,818 | $15,199 | $1,238 | -$540 |
| Other Non-Cash | -$18,034 | $19,102 | -$5,426 | $39 |
| Operating Cash Flow | -$43,873 | -$22,608 | -$26,240 | -$23,573 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$53 | -$116 | -$316 | -$97 |
| Net Acquisitions | $0 | $0 | -$4 | $38 |
| Inv. Purchases | -$26,350 | -$47,588 | -$44,000 | -$78,000 |
| Inv. Sales/Matur. | $55,778 | $49,329 | $48,322 | $39,873 |
| Other Inv. Act. | -$1 | -$181 | $4 | -$38 |
| Investing Cash Flow | $29,374 | $1,444 | $4,006 | -$38,224 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $4,279 | -$1,988 | $6,074 | -$3,572 |
| Stock Issued | $16,357 | $14,089 | $14,359 | $50,407 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $22 | $2,955 | $5 | $10,914 |
| Financing Cash Flow | $20,658 | $15,056 | $20,438 | $57,749 |
| Forex Effect | $22 | -$224 | -$607 | $207 |
| Net Chg. in Cash | $6,181 | -$6,332 | -$2,403 | -$3,841 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,255 | $10,587 | $12,990 | $16,831 |
| End Cash | $10,436 | $4,255 | $10,587 | $12,990 |
| Free Cash Flow | -$43,927 | -$22,905 | -$26,556 | -$23,670 |